STTR funding for developing extracellular vesicle therapeutic platforms for regenerative medicine (clinical trial not allowed)
This funding opportunity supports platform-focused R&D to develop novel extracellular vesicle (EV) therapeutics for regenerative medicine, including work related to production, manufacturing, and therapeutic use. The notice specifies that clinical trial activities are not allowed under this opportunity, and it uses STTR cooperative agreement mechanisms.
This FOA provides support using the STTR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated the ability for specific and targeted tissue and organ repai…
Funding Source
Awards & funding
Eligibility
Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.S…
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers